Search results
ASCO 2024: Merus touts positive Phase II data for head and neck cancer antibody
Pharmaceutical Technology via Yahoo Finance· 2 days agoThe Phase II study is evaluating petosemtamab in combination with Merck & Co’s PD-1 inhibitor...
Madison-based life science company Mirus Bio to be acquired for $600 million
Small Business Times· 2 days agoMadison-based Mirus Bio, a manufacturer of transfection regents used in gene therapies, has entered...
Dow Jones Rises Ahead Of Inflation Report; AI Stock Workday Plunges On Earnings
Investor's Business Daily· 2 days agoToday: Best Stocks To Watch Monday.com, Netflix and Nvidia chipmaker Taiwan Semiconductor...
Futures: AI Stock Leader Plunges On Earnings
Investor's Business Daily· 5 days agoThe Dow Jones Industrial Average dropped nearly 200 points Monday. Palo Alto plunged late.
Week Ahead for FX, Bonds: U.S. and Eurozone Inflation, China PMIs in Focus
The Wall Street Journal· 2 days agoFocus this week will center on U.S. PCE inflation data as uncertainty remains over when the Federal...
Dow Jones Falls Ahead Of Fed Minutes; Nvidia Slides Ahead Of Earnings
Investor's Business Daily· 4 days agoMicrosoft and Trade Desk are featured in this Stocks Near A Buy Zone column. An essential resource...
‘It made my penis change shape’: Inside the hair loss drug controversy
The Telegraph via Yahoo News· 4 days agoA few years ago, James* was at the pub with colleagues when a female co-worker walked behind him to...
Dow Jones Falls After Jobless Claims; Nvidia Surges Above 1,000 On Earnings
Investor's Business Daily· 3 days agoMicrosoft was featured in IBD's Stocks Near A Buy Zone column. An essential resource for breakouts...
Dow Drops 300 Points
Barrons.com· 3 days agoThe Dow was down 300 points on Thursday. The only stocks in the index that were trading higher were Merck, Walmart, Microsoft and Amazon.com. The S&P 500...
A new pill cures preschoolers of a parasitic worm. Delivering it could be a challenge
NPR· 6 days ago"So close because the medicine is available and so far because the funding for procurement and the...